Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains

Microbial Pathogenesis

Volumn 26, Issue 3, 1999, Pages 121-130

  Zhang, Xin ^a   Kelly, Sandra M ^a,b   Bollen, Wendy ^a   Curtiss III, Roy ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Megan Health Inc   (United States)

Author keywords

Attenuated Salmonella vaccine; Oral immunization; Protective immunity; S. typhimurium; Splenomegaly; Virulence plasmid; crp; cya

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; OUTER MEMBRANE PROTEIN; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTESTINE LYMPHATIC TISSUE; LIVER; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMID; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPLEEN;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; NEGIBACTERIA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0033103025     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1998.0245     Document Type: Article

References (42)

1. Centers for Disease Control. Human Salmonella isolates - United states. 1983. Morbid Mortal Weekly Rep 1984; 33: 693-5.
2. Carter PB, Collins FM. The route of enteric infection in normal mice. J Exp Med 1974; 139: 1189-203.
3. Asherson GL, Zembala M, Perera MACC, Mayhew B, Thomas WR. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol 1977; 33: 145-55.
4. Bienenstock J, McDermott M, Befus D, O'Neill M. A common mucosal immunologic system involving the bronchus, breast and bowel. Adv Exp Med Biol 1978; 107: 53-9.
5. Cebra JJ, Gearhart PJ, Kamat R, Robertson SM, Tseng J. Origin and differentiation of lymphocytes involved in the secretory IgA response. Cold Spring Harbor Symp Quant Biol 1976; 41: 201-15.
6. Collins FM. Vaccines and cell-mediated immunity. Bacteriol Rev 1974; 38: 371-6.
7. McCaughan G, Basten A. Immune system of the gastrointestinal tract. Int Rev Physiol 1983; 28: 131-57.
8. Nair R, Kamat RS. Effector cell-mediated immune response in mice immunized with Salmonella. J Med Microb 1982; 15: 215-21.
9. Curtiss R III. Attenuated Salmonella strains as live vectors for the expression of foreign antigens. In: Woodrow GC, Levine MM, Eds. New Generation Vaccines. New York: Marcel Dekker, 1990: 161-88.
10. Curtiss R III, Kelly SM, Tinge SA, et al. Recombinant Salmonella vectors in vaccine development. Dev Biol Stand 1994; 82: 23-33.
11. Cardenas L, Clements JD. Oral immunization using live attenuated Salmonella spp. As carriers of foreign antigens. Clinical Microb Rev 1992; 5: 328-342.
12. Clements JD, Chong C, Bost KL. Use of attenuated Salmonella vectors for oral vaccines. In: Kagnoff MF, Kiyono H, Eds. Essentials of Mucosal Immunology. San Diego: Academic Press, 1996: 513-42.
13. Levine MM, Galen J, Barry E, et al. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors. J Biotechnol 1996; 44: 193-6.
14. Germanier R, Furer E. Immunity in experimental salmonellosis. II. Basis for the virulence and protective capacity of galE mutants of Salmonella typhimurium. Infect Immun 1971; 4: 663-73.
15. Germanier R, Furer E. Isolation and characterization of galE mutant Ty21a of Salmonella typhi: A candidate strain for a live, oral typhoid vaccine. J Infect Dis 1975; 131: 553-5.
16. Hoiseth SK, Stocker BAD. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291: 238-239.
17. Curtiss R III, Kelly SM. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic receptor protein are avirulent and immunogenic. Infect Immun 1987; 55: 3035-43.
18. Galan JE, Curtiss R III. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb Pathog 1989; 6: 433-43.
19. Dorman CJ, Chatfield S, Higgins CF, Hayward C, Dougan G. Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo. Infect Immun 1989; 57: 2136-40.
20. Chatfield SN, Strahan K, Pickard D, Charles IG, Hormaeche CE, Dougan G. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb Pathog 1992; 12: 145-51.
21. Kelly SM, Bosecker BA, Curtiss R III. Characterization and protective properties of attenuated mutants of Salmonella choleraesuis. Infect Immun 1992; 60: 4881-90.
22. Zhang X, Kelly SM, Curtiss R. Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 δcrp and δcdt deletion mutants. Infect Immun 1997; 65: 5381-7.
23. Curtiss R III, Porter SB, Munson M, et al. Non-recombinant and recombinant avirulent Salmonella live vaccines for poultry. In: Blakenship LC, Bailey JS, Cox NA, Stern NJ, Meinersmann RJ, Eds. Colonization Control of Human Bacterial Enteropathogens in Poultry. New York: Academic Press, 1991: 169-98.
24. Hassan JO, Curtiss R III. Control of colonization by virulent Salmonella typhimurium by oral immunization of chickens with avirulent δcrp δcya S. typhimurium. Res Microbiol 1990; 141: 839-50.
25. Hassan JO, Curtiss R III. Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes. Infect Immun 1994; 62: 5519-27.
26. Hassan JO, Curtiss R III. Effect of vaccination of hens with an avirulent strain of Salmonella typhimurium on immunity of progeny challenged with wild-type Salmonella strains. Infect Immun 1996; 64: 938-44.
27. O'Callaghan DD, Masckell F, Liew Y, Easmon CSF, Dougan G. Characterization of aromatic-and purine-dependent Salmonella typhimurium: Attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect Immun 1988; 56: 419-23.
28. Killar LM, Eisenstein TK. Immunity to Salmonella infection in C3H/HeJ and C3H/HeNCrlBr mice: Studies with an aromatic-dependent live S. typhimurium strain as a vaccine. Infect Immun 1985; 47: 605-12.
29. Hoertt BE, Ou J, Kopecko DJ, Baron LS, Warren RL. Novel virulence properties of the Salmonella typhimurium virulence-associated plasmid: Immune suppression and stimulation of splenomegaly. Plasmid 1989; 21: 48-58.
30. Gulig PA. Virulence plasmid of Salmonella typhimurium and other salmonellae. Microb Pathog 1990; 8: 3-11.
31. + expression-cloning vector: Stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio Technol 1988; 6: 693-7.
32. Galan JE, Nakayama K, Curtiss R III. Cloning and characterization of the asd gene of Salmonella typhimurium: Use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 1990; 94: 29-35.
33. Curtiss R III, Doggett T, Nayak A, Srinivasan J. Strategies for the use of live recombinant avirulent bacterial vaccines for mucosal immunization. In: Kagnoff MF, Kiyono H, Eds. Essentials of Mucosal Immunology. San Diego: Academic Press, 1996: 499-511.
34. Smerdou C, Anton IM, Plana J, Curtiss R III, Enjuanes L. A continuous epitope from transmissible gastroenteritis virus S protein fused to E. Coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity. Virus Research 1996; 41: 1-9.
35. Gentry-Weeks CR, Hultsch AL, Kelly SM, Keith JM, Curtiss R III. Cloning and sequencing of a gene encoding a 21-kilodalton outer membrane protein from Bordetella avium and expression of the gene in Salmonella typhimurium. J Bact 1992; 174: 7729-42.
36. Cieslak PR, Zhang T, Stanley SL Jr. Expression of a recombinant Entamoeba histolytica antigen in a Salmonella typhimurium vaccine strain. Vaccine 1993; 11: 773-6.
37. Tinge SA, Curtiss R III. Isolation of the replication and partitioning regions of the Salmonella typhimurium virulence plasmid and stabilization of heterologous replicons. J Bact 1990; 58: 3084-92.
38. Luria SE, Burrous JW. Hybridization between Escherichia coli and Shigella. J Bact 1957; 74: 461-76.
39. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bact 1983; 154: 269-77.
40. Tsai CM, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 1982; 119: 115-19.
41. Curtiss R III. Chromosomal aberrations associated with mutations to bacteriophage resistance in Escherichia coli. J Bact 1965; 89: 28-40.
42. Srisart P, Reynolds BL, Rowley D. The correlation between serum IgA antibody levels and resistance to infection with Salmonella typhimurium after oral immunization with various salmonellae. Aust J Exp Med Sci 1985; 63: 177-82.